Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjögren M, Andreasen N, Blennow K.

Neurosci Lett. 2000 May 5;285(1):49-52.

PMID:
10788705
2.

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H.

Arch Neurol. 2002 Aug;59(8):1267-72.

PMID:
12164722
3.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K.

Arch Gen Psychiatry. 2004 Jan;61(1):95-102.

PMID:
14706948
4.

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Laske C, Stransky E, Fritsche A, Eschweiler GW, Leyhe T.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):80-5. doi: 10.1007/s00406-008-0838-3. Epub 2008 Sep 19.

PMID:
18806919
5.

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature.

Lewczuk P, Esselmann H, Bibl M, Beck G, Maler JM, Otto M, Kornhuber J, Wiltfang J.

J Mol Neurosci. 2004;23(1-2):115-22.

PMID:
15126697
6.

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

Ishiguro K, Ohno H, Arai H, Yamaguchi H, Urakami K, Park JM, Sato K, Kohno H, Imahori K.

Neurosci Lett. 1999 Jul 30;270(2):91-4.

PMID:
10462105
7.

Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease.

Schönknecht P, Pantel J, Hunt A, Volkmann M, Buerger K, Hampel H, Schröder J.

Neurosci Lett. 2003 Mar 20;339(2):172-4.

PMID:
12614922
8.

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC.

Arch Neurol. 2003 Sep;60(9):1209-13.

PMID:
12975285
9.

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

Kohnken R, Buerger K, Zinkowski R, Miller C, Kerkman D, DeBernardis J, Shen J, Möller HJ, Davies P, Hampel H.

Neurosci Lett. 2000 Jun 30;287(3):187-90.

PMID:
10863026
10.

Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.

Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A, Kluenemann H, Wieland W, Hajak G.

Neurobiol Aging. 2006 Sep;27(9):1202-11. Epub 2005 Aug 8.

PMID:
16085339
11.

Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.

Maccioni RB, Lavados M, Guillón M, Mujica C, Bosch R, Farías G, Fuentes P.

Neurobiol Aging. 2006 Feb;27(2):237-44. Epub 2005 Apr 7.

PMID:
16399209
12.

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F; Phospho-Tau International Study Group..

Neurol Sci. 2001 Feb;22(1):77-8.

PMID:
11487210
13.

[The measurement of phosphorylated tau in human cerebrospinal fluid as a diagnostic marker for Alzheimer's disease].

Urakami K, Ito N, Arai H, Ishiguro K, Ohno H, Nakashima K.

Seishin Shinkeigaku Zasshi. 2003;105(4):393-7. Japanese.

PMID:
12806900
14.

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

Vandermeeren M, Mercken M, Vanmechelen E, Six J, van de Voorde A, Martin JJ, Cras P.

J Neurochem. 1993 Nov;61(5):1828-34.

PMID:
8228996
15.
16.

Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia.

Ravaglia S, Bini P, Sinforiani E, Franciotta D, Zardini E, Tosca P, Moglia A, Costa A.

Neurol Sci. 2008 Dec;29(6):417-23. doi: 10.1007/s10072-008-1023-1. Epub 2008 Nov 14.

PMID:
19011737
17.

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease.

Itoh N, Arai H, Urakami K, Ishiguro K, Ohno H, Hampel H, Buerger K, Wiltfang J, Otto M, Kretzschmar H, Moeller HJ, Imagawa M, Kohno H, Nakashima K, Kuzuhara S, Sasaki H, Imahori K.

Ann Neurol. 2001 Aug;50(2):150-6.

PMID:
11506396
18.

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).

Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S.

Neurochem Int. 2009 Sep;55(4):214-8. doi: 10.1016/j.neuint.2009.02.017. Epub 2009 Mar 5.

PMID:
19524111
19.

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

Green AJ, Harvey RJ, Thompson EJ, Rossor MN.

Neurosci Lett. 1999 Jan 8;259(2):133-5.

PMID:
10025576
20.

Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.

Leszek J, Małyszczak K, Janicka B, Kiejna A, Wiak A.

Med Sci Monit. 2003 Nov;9(11):CR484-8.

PMID:
14586274

Supplemental Content

Support Center